Westside Investment Management’s Abiomed Inc ABMD Stock Holding History

Westside Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$65	Buy	+250	New	+$66.3K	﹤0.01%	289

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Westside Investment Management's ABMD Position: Q2 2019 in Review

Westside Investment Management opened a new position in Abiomed Inc (ABMD) in Q2 2019: 250 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #289 among its holdings.

483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

Westside Investment Management held 250 shares of Abiomed Inc worth $65 as of Q2 2019.
Abiomed Inc was a new Westside Investment Management position in Q2 2019.
Abiomed Inc made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2019, its #289 holding.
483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Westside Investment Management's 13F filing for Q2 2019, filed 24 Jul 2019.